Massive Problem Martin Shkreli Zeroed-In On Is Happening Again
It's easy to write off Martin Shkreli and his dramatic price hike of a 62-year-old drug by 5,000% as a one-time deal.
But that's not the case. Price hikes in the pharmaceutical industry are incredibly common: Earlier this month, Reuters reported that pharma giant Pfizer raised prices on more than 100 of its drugs.
But that's not the case. Price hikes in the pharmaceutical industry are incredibly common: Earlier this month, Reuters reported that pharma giant Pfizer raised prices on more than 100 of its drugs.